Publicacións nas que colabora con Laura Muinelo Romay (56)

2024

  1. Genome-wide DNA methylation profiling in tongue squamous cell carcinoma

    Oral Diseases, Vol. 30, Núm. 2, pp. 259-271

  2. Identification of a Proteomic Signature for Predicting Immunotherapy Response in Patients With Metastatic Non-Small Cell Lung Cancer

    Molecular and Cellular Proteomics, Vol. 23, Núm. 10

2023

  1. Epigenomic reprogramming of therapy-resistant circulating tumor cells in colon cancer

    Frontiers in Cell and Developmental Biology, Vol. 11

  2. Erratum: Correction: Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer (Cancer research (2017) 77 21 (5846-5859))

    Cancer research

  3. Immunotherapy in patients with brain metastasis: advances and challenges for the treatment and the application of circulating biomarkers

    Frontiers in Immunology, Vol. 14

  4. Noninvasive detection of microsatellite instability in patients with endometrial cancer

    International Journal of Cancer, Vol. 152, Núm. 10, pp. 2206-2217

  5. Somatic mutations in tumor and plasma of locoregional recurrent and/or metastatic head and neck cancer using a next-generation sequencing panel: A preliminary study

    Cancer Medicine, Vol. 12, Núm. 6, pp. 6615-6622

2022

  1. Improving the Management of Endometrial Cancer Patients through the Use of Liquid Biopsy Analyses: A Case Report

    International Journal of Molecular Sciences, Vol. 23, Núm. 15

  2. Integrity and quantity of salivary cell-free DNA as a potential molecular biomarker in oral cancer: A preliminary study

    Journal of Oral Pathology and Medicine, Vol. 51, Núm. 5, pp. 429-435

  3. Methods for the Detection of Circulating Biomarkers in Cancer Patients

    Advances in experimental medicine and biology, Vol. 1379, pp. 525-552

  4. Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA

    Clinical Epigenetics, Vol. 14, Núm. 1

  5. Plasma cell-free DNA and circulating tumor cells as prognostic biomarkers in small cell lung cancer patients

    Translational Lung Cancer Research, Vol. 11, Núm. 10, pp. 1995-2009

2021

  1. Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non-small-cell lung cancer treated with pembrolizumab

    Molecular Oncology, Vol. 15, Núm. 11, pp. 2923-2940

  2. Current status and future perspectives of liquid biopsy in small cell lung cancer

    Biomedicines, Vol. 9, Núm. 1, pp. 1-22

  3. Epigenetic Landscape of Liquid Biopsy in Colorectal Cancer

    Frontiers in Cell and Developmental Biology, Vol. 9

  4. Evaluation of a targeted next-generation sequencing panel for the non-invasive detection of variants in circulating dna of colorectal cancer

    Journal of Clinical Medicine, Vol. 10, Núm. 19

  5. Letter to the editor: “Liquid biopsy based on saliva cell-free DNA as a potential biomarker for head and neck cancer”

    Oral Oncology

  6. Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers

    Clinical and Experimental Metastasis, Vol. 38, Núm. 2, pp. 239-251

  7. Morphological abnormalities and gene expression changes caused by high incubation temperatures in zebrafish xenografts with human cancer cells

    Genes, Vol. 12, Núm. 1, pp. 1-12

  8. Salivary dna methylation as an epigenetic biomarker for head and neck cancer. Part i: A diagnostic accuracy meta-analysis

    Journal of Personalized Medicine, Vol. 11, Núm. 6